Team Detection of Anti-MSH2 Antibody as a Diagnostic Biomarker for Colon Tumors MSH2, a crucial component of the DNA mismatch repair (MMR) system, is frequently implicated in the pathogenesis of colorectal cancer (CRC). Immunohistochemistry (IHC) utilizing anti-MSH2 antibodies en... Jun 14, 2024
Team Diagnostic Potential of SOX11 Antibody in Ovarian Tumors: A Comprehensive Immunohistochemical Analysis Ovarian tumors present significant challenges in accurate diagnosis and classification due to their diverse histopathological features. SOX11, a member of the SOX (SRY-related HMG-box) family of trans... Jun 14, 2024
Team Localization and Function of Cysteine Protease Inhibitor C (CST3) Antibodies in the Nervous System Cysteine protease inhibitors, particularly cystatin C (CST3), are crucial in regulating proteolytic activities within the nervous system. CST3 is a potent endogenous inhibitor of cysteine proteases, s... Jun 13, 2024
Team The Role of FN1 Antibodies in Brain Cancer Targeting: A Comprehensive Review Fibronectin 1 (FN1) is a glycoprotein widely expressed in the extracellular matrix and plays a crucial role in cell adhesion, migration, and signaling. In the context of brain cancer, FN1 has emerged ... Jun 12, 2024
Team Exploring EGFR Antibodies as Targeted Therapies for Brain Cancer: Mechanisms and Clinical Progression Brain cancer, particularly glioblastoma multiforme (GBM), remains one of the most challenging malignancies to treat due to its invasive nature and resistance to conventional therapies. Among the vario... Jun 12, 2024
Team Evaluation of CD3E Antibodies as a Potential Therapeutic Target in Brain Cancer CD3E antibodies have emerged as promising therapeutic agents for brain cancer treatment due to their ability to target and modulate the immune response against tumor cells. This review provides a tech... Jun 12, 2024
Team Targeting CD274 Antibodies in Brain Cancer: A Promising Therapeutic Approach Brain cancers, particularly glioblastomas, present significant therapeutic challenges due to their aggressive nature and poor prognosis. Recent advancements in immunotherapy have highlighted the poten... Jun 12, 2024
Team Characterization of Human T-lymphotropic Virus 2 (HTLV-2) p24 Capsid Protein Antibodies: Implications for Diagnosis and Vaccine Development Human T-lymphotropic virus 2 (HTLV-2) is a retrovirus primarily associated with certain populations, particularly Indigenous communities in the Americas. The p24 capsid protein of HTLV-2 plays a cruci... May 30, 2024
Team Characterization of SRPK Antibodies: Applications in Studying Serine-Arginine Protein Kinase Biology Serine-Arginine Protein Kinases (SRPKs) constitute a pivotal group of enzymes orchestrating pre-mRNA splicing, a central event in eukaryotic gene expression. This article delves into the technical nua... May 16, 2024
Team Unraveling the Role of TNFRSF10B Antibodies in Death Receptor Signaling Pathway The tumor necrosis factor receptor superfamily member 10B (TNFRSF10B), also known as Death Receptor 5 (DR5), is a pivotal player in apoptosis induction through the extrinsic pathway. Its involvement i... Apr 16, 2024
Team Investigating the Role of TNFRSF10A Antibodies in Death Receptor Signaling Pathway Research The tumor necrosis factor receptor superfamily member 10A (TNFRSF10A), commonly referred to as Death Receptor 4 (DR4), stands as a pivotal regulator in the initiation of apoptosis through the extrinsi... Apr 16, 2024
Team Exploring the Role of CFLAR Antibodies in Death Receptor Signaling Pathway Research Within the intricate landscape of cellular signaling pathways, the Death Receptor Signaling Pathway (DRSP) holds a pivotal role in orchestrating programmed cell death, or apoptosis. At the core of thi... Apr 16, 2024